4.8 Article

Reduced B12 uptake and increased gastrointestinal formate are associated with archaeome-mediated breath methane emission in humans

Journal

MICROBIOME
Volume 9, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s40168-021-01130-w

Keywords

Archaeome; Microbiome; Methanogens; Methane; Gut; Gastrointestinal tract; Metabolome; Metagenome; Methanobrevibacter; Christensenellaceae

Categories

Funding

  1. Austrian Science Fund (FWF) [P 32697, KLI 639, P28854, I3792, DK-MCD W1226]
  2. Austrian Research Promotion Agency (FFG) [864690, 870454]
  3. Integrative Metabolism Research Center Graz
  4. Austrian Infrastructure Program 2016/2017
  5. Styrian Government (Zukunftsfonds)
  6. BioTechMed-Graz (Flagship project DYNIMO)
  7. Austrian Science Fund (FWF) [I3792] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

The study identified that high methane emitters have a significant increase in Methanobrevibacter smithii in their microbiome, which co-occurs with a bacterial community specialized in dietary fiber degradation. High methane producers also show increased levels of formate and acetate in the gut, closely correlated with dietary habits and microbiome function, driving archaeal methanogenesis.
Background: Methane is an end product of microbial fermentation in the human gastrointestinal tract. This gas is solely produced by an archaeal subpopulation of the human microbiome. Increased methane production has been associated with abdominal pain, bloating, constipation, IBD, CRC or other conditions. Twenty percent of the (healthy) Western populations innately exhale substantially higher amounts (>5 ppm) of this gas. The underlying principle for differential methane emission and its effect on human health is not sufficiently understood. Results: We assessed the breath methane content, the gastrointestinal microbiome, its function and metabolome, and dietary intake of one-hundred healthy young adults (female: n = 52, male: n = 48; mean age =24.1). On the basis of the amount of methane emitted, participants were grouped into high methane emitters (CH4 breath content 5-75 ppm) and low emitters (CH4 < 5 ppm). The microbiomes of high methane emitters were characterized by a 1000-fold increase in Methanobrevibacter smithii. This archaeon co-occurred with a bacterial community specialized on dietary fibre degradation, which included members of Ruminococcaceae and Christensenellaceae. As confirmed by metagenomics and metabolomics, the biology of high methane producers was further characterized by increased formate and acetate levels in the gut. These metabolites were strongly correlated with dietary habits, such as vitamin, fat and fibre intake, and microbiome function, altogether driving archaeal methanogenesis. Conclusions: This study enlightens the complex, multi-level interplay of host diet, genetics and microbiome composition/function leading to two fundamentally different gastrointestinal phenotypes and identifies novel points of therapeutic action in methane-associated disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available